We recently updated our Privacy Notice and Terms of Use.
Med-IQ

Course Listings: Oncology

All Results (15)
Format: Live Events (1) Online Activities (14)

Decision-IQ: A Case Study in Managing Biochemical Recurrence of Prostate Cancer

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: In this short case-based activity, meet Ed, a 59-year-old man who experiences a biochemical recurrence of prostate cancer. As you move through this activity, read through links to useful resources to help you make clinical management decisions for this patient. In addition, find out how Judd Moul, MD, would manage Ed’s recurrence to help reduce his risk of…More


Challenges in Disease Management for Type 1 Gaucher Disease

View Course

Format: Live Event

Maximum Credits: 4.5

Course Description: This live meeting will improve clinician’s knowledge of the variable presentation of GD1 in children, adolescents and adults in order to facilitate earlier diagnosis and determine appropriate management. Clinicians will also discuss genetic testing and prenatal and newborn screening and review the importance of counseling patients with GD1 that are planning to…More


Advances in Breast Cancer

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: This 30-minute webcast reviews recent updates and current clinical evidence in breast cancer management, including the latest surgical techniques, the use of genomic medicine in HR+/HER2- early stage breast cancer, and radiotherapy fractionation for early stage breast cancer.


Advances in the Management of Brain Metastases

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: In this 30-minute webcast, expert faculty review recent advances in the management of brain malignancies. In particular, April K.S. Salama, MD, discusses the current understanding of systemic therapy, John Kirkpatrick, MD, PhD, discusses advances in radiation therapy, and Peter Fecci, MD, PhD, discusses surgical improvements for brain metastasis.


Advances in the Treatment of Renal Cell Carcinoma

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: In this 30-minute webcast, expert faculty discuss recent advances in the treatment of renal cell carcinoma.


Recent Advances in the Treatment of Hematologic Malignancies

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: In this 30-minute webcast, expert faculty explore recent advances in the treatment of hematologic malignancies. In particular, CAR T-cell therapy for relapsed and refractory diffuse large B-cell lymphoma and FLT3-targeted treatment in AML are discussed.


Recent Therapeutic Advances for Thoracic Malignancies

View Course

Format: Webcast

Maximum Credits: 0.5

Course Description: In this 30-minute webcast, expert faculty highlight recent clinical evidence on the care of patients with thoracic malignancies. The role of surgery and radiotherapy in treating patients with small cell and non–small cell lung cancer in the era of immunotherapy is discussed, as well as the current standard of care for patients with metastatic non–small cell…More


GFR and eGFR: Filtering Out the Confusion

View Course

Format: E-Publication

Maximum Credits: 1.0

Course Description: Nephrologist Dr. Michael Wiederkehr delves into chronic kidney disease (CKD) and the difference between true glomerular filtration rate (GFR) and estimated glomerular filtration rate (eGFR). The different methods of calculating eGFR will be explored as well as the pitfalls and limitations of the current formulas and calculations. The importance of the CKD…More


Decision-IQ: Assessing Risk and Preventing Tumor Lysis Syndrome

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: This brief case-based, digital CME activity incorporates current evidence-based prophylaxis algorithms to assess the risk of tumor lysis syndrome (TLS) in a patient with chronic lymphocytic leukemia (CLL) undergoing anticancer therapy. Links to relevant literature and expert insights are provided to help clinicians prevent and manage TLS.


Decision-IQ: Prostate Cancer Screening in the Geriatric Population

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: This interactive case-based activity discusses the risks and benefits of prostate cancer screening in the geriatric population. Links to useful resources are provided to help participants make treatment decisions for the patient, and expert faculty offer their perspectives on the latest evidence for these management decisions.


Raising the Bar in NHL Through the Provision of Shared Decision Making

View Course

Format: E-Publication

Maximum Credits: 0.5

Course Description: This 30-minute, interactive digital publication interweaves clinical patient cases as well as patient, caregiver, and clinician insights from national surveys to examine the role of shared decision making in non-Hodgkin lymphoma. Evidence-based guideline recommendations for managing patients with follicular lymphoma and diffuse large B-cell lymphoma, as well as…More


Decision-IQ: Updates in the Diagnosis and Treatment of an Ocular Surface Mass

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: In this brief case-based activity, meet Bob, a 62-year-old man who initially presented with redness in his left eye and was referred to the Duke Eye Center. As you move through this activity, read through links to useful resources to help you make clinical management decisions for Bob. You will also receive insights from expert faculty Gargi Vora, MD, on the…More


Decision-IQ: Genetic Risk Assessment and Testing for Hereditary Ovarian Cancer

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: In this brief case-based activity, meet Karen, a fictional 30-year-old woman whose mother recently died of ovarian cancer. Karen is now asking whether she should undergo genetic testing or ovarian cancer screening. As you move through this activity, read through links to useful resources to help you make clinical management decisions for Karen. You will also…More


Keeping Up With CDK 4/6 Therapy in HR-Positive, HER2-Negative Advanced Breast Cancer

View Course

Format: E-Publication

Maximum Credits: 1.0

Course Description: This online CME publication explores the changing treatment landscape in hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. In particular, it addresses questions related to the appropriate use of cyclin-dependent kinase 4/6 inhibitors in practice and details their similarities and…More


The Rapidly Evolving Role of Biosimilars: Educating Specialists and Facilitating Shared Decision Making With Patients

View Course

Format: E-Publication

Maximum Credits: 0.75

Course Description: This accredited CME publication describes biosimilars and how they compare with their originator products, reviews FDA guidance on the biosimilar approval process, and discusses key issues for prescribers. In addition, brief clinical case vignettes present examples of how biosimilars may appear in practice.